2 results
Approved WMOCompleted
To compare skin condition for monitoring with the Bambi Belt versus skin condition with routine monitoring.
Approved WMOCompleted
The primary objective is to assess the efficacy of nemolizumab (CD14152) compared to placebo in subjects >= 18 years of age with prurigo nodularis (PN) after a 16-week treatment period.